Author:
Wallach Elisabeth,Ehlinger Virginie,Biotteau Maelle,Walther-Louvier Ulrike,Péréon Yann,Vuillerot Carole,Fontaine Stephanie,Sabouraud Pascal,Espil-Taris Caroline,Cuisset Jean-Marie,Laugel Vincent,Baudou Eloïse,Arnaud Catherine,Cances Claude
Abstract
AbstractDuchenne Muscular Dystrophy (DMD) is a neuromuscular disease that inevitably leads to total loss of autonomy. The new therapeutic strategies aim to both improve survival and optimise quality of life. Evaluating quality of life is nevertheless a major challenge. No DMD-specific quality of life scale to exists in French. We therefore produced a French translation of the English Duchenne Muscular Dystrophy module of the Pediatric Quality of Life Inventory (PedsQLTMDMD) following international recommendations. The study objective was to carry out a confirmatory validation of the French version of the PedsQLTMDMD for paediatric patients with DMD, using French multicentre descriptive cross-sectional data. The sample consisted of 107 patients. Internal consistency was acceptable for proxy-assessments, with Cronbach's alpha coefficients above 0.70, except for the Treatment dimension. For self-assessments, internal consistency was acceptable only for the Daily Activities dimension. Our results showed poor metric qualities for the French version of the PedsQLTMDMD based on a sample of about 100 children, but these results remained consistent with those of the original validation. This confirms the interest of its use in clinical practice.
Publisher
Springer Science and Business Media LLC
Subject
Pediatrics, Perinatology and Child Health